Any hemoglobin that contains a
mutation is a variant hemoglobin. A mutation can involve a
delete of all or a portion of the gene leading to a reduced or
absent production of globin proteins, or small changes in the
DNA that affect the genes ability to function normally leading
to the production of different types of hemoglobin. A mutation
on chromosome 16 in the alpha globin gene can produce a
different hemoglobin such as Constant Spring. However, mutations
in this gene usually lead to the inactivation of the alpha
globin protein production coded by the gene. A mutation can
occur on chromosome 11, affecting one of the beta globins,
leading to an abnormal hemoglobin. Beta globin gene mutations
can lead to decreased production as well as inactivation of the
gene. Not all of these mutations have been defined with DNA
analysis, though many of them have and many are constantly being
defined.
There are over 150 known mutations in the beta globin gene,
producing beta thalassemia trait in the heterzygotic individual,
and causing a variable degree of anemia in the homozygote. In
addition, there are mutations such as that leading to hemoglobin
E, which do not produce disease even in the homozygous state.
However, hemoglobin E combined with other variant beta globins
can produce mild to severe anemia. Many variant hemoglobins
exist worldwide. Hemoglobins E and S are significant because
they can be co-inherited with thalassemia trait to produce a
disease that requires treatment. Hemoglobin E is very common
among Southeast Asians; California Newborn Screening Program
found that 1 in 12 Southeast Asians, and 1 in 4 Cambodian
newborns had Hgb E trait. Hgb EE (homozygous) has not been shown
to have serious medical implications. Hgb E-Beta thalassemia has
a wide range of clinical manifestations, from mild anemia to
significant anemia requiring chronic tranfusions.
Hemoglobin S (sickle cell) is prevalent among Africans and
African Americans. Hgb S and beta thalassemia trait can be
co-inherited to produce sickle beta zero (SB0) thalassemia. The
clinical manifestations of this disease resemble Hgb SS disease.